Matches in Nanopublications for { ?s ?p "[MDM2 is consistently amplified in well-differentiated liposarcomas/atypical lipomatous tumors, and up to 25% in other sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP768816.RAwDVLLWdy0J1Bx6mRxXYRINaCHJL94fU5T98ATKmWflY130_assertion description "[MDM2 is consistently amplified in well-differentiated liposarcomas/atypical lipomatous tumors, and up to 25% in other sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768816.RAwDVLLWdy0J1Bx6mRxXYRINaCHJL94fU5T98ATKmWflY130_provenance.
- NP768819.RASY8tyC-R15n5Ndhlnrbz7_1OkFnS5hRWC0LyJ9F02v4130_assertion description "[MDM2 is consistently amplified in well-differentiated liposarcomas/atypical lipomatous tumors, and up to 25% in other sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768819.RASY8tyC-R15n5Ndhlnrbz7_1OkFnS5hRWC0LyJ9F02v4130_provenance.
- assertion description "[MDM2 is consistently amplified in well-differentiated liposarcomas/atypical lipomatous tumors, and up to 25% in other sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[MDM2 is consistently amplified in well-differentiated liposarcomas/atypical lipomatous tumors, and up to 25% in other sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.